SCHEMBL3785359

SCHEMBL3785359

CCOC(=O)C1C(CN2C(=O)c3ccccc3C2=O)C1C(=O)OC

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.46
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
KDM4E B2RXH2 2/20 0.45
HSD17B10 Q99714 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.42
MAPT P10636 2/20 0.41
HPGD P15428 2/20 0.41
PLIN1 O60240 1/20 0.41
ALOX15 P16050 1/20 0.41
PLIN5 Q00G26 1/20 0.41
ABHD5 Q8WTS1 1/20 0.41
TSHR P16473 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C19 P33261 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
TDP1 Q9NUW8 1/20 0.40
GAA P10253 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3777633 0.90 ALDH1A1 (0.48) ALDH1A1KMT2AMEN1KDM4EL3MBTL1
SCHEMBL3770141 0.79 ALDH1A1 (0.43) ALDH1A1KMT2AMEN1HSD17B10MAPT
SCHEMBL3770265 0.78 ALDH1A1 (0.51) ALDH1A1KMT2AMEN1HSD17B10MAPT
SCHEMBL3783014 0.77 ALDH1A1 (0.39) ALDH1A1KMT2AMEN1HSD17B10L3MBTL1
SCHEMBL3781291 0.77 ALDH1A1 (0.39) ALDH1A1KMT2AMEN1HSD17B10L3MBTL1
SCHEMBL3777053 0.77 ALDH1A1 (0.39) ALDH1A1KDM4EHSD17B10MAPTHPGD
SCHEMBL27852525 0.76 KDM4E (0.45) ALDH1A1KMT2AMEN1KDM4EL3MBTL1
SCHEMBL3772347 0.76 SLC6A4 (0.47) CYP1A2CYP2C19
SCHEMBL15265352 0.74 ALDH1A1 (0.60) ALDH1A1KMT2AMEN1KDM4EHSD17B10
SCHEMBL8528965 0.73 ALDH1A1 (0.43) ALDH1A1KMT2AMEN1KDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100324305-A1 PRODUCTION METHOD OF POLYCYCLIC LACTAMS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-12-23 US disclosed
US-20090118519-A1 Production Method of Polycyclic Lactams SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-05-07 US disclosed
EP-2014647-A1 PROCESS FOR PRODUCING POLYCYCLIC LACTAM Sumitomo Chemical Company, Limited (JP) 2009-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118519-A1 Production Method of Polycyclic Lactams MRPL21, COASY, ASNS ALDH1A1 1979/4885KMT2A 1271/4885MEN1 495/4885
US-20100324305-A1 PRODUCTION METHOD OF POLYCYCLIC LACTAMS COASY, MRPL21, ASNS ALDH1A1 1821/4885KMT2A 1135/4885MEN1 393/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.